Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling
出版年份 2023 全文链接
标题
Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 7, Pages 6619
出版商
MDPI AG
发表日期
2023-04-03
DOI
10.3390/ijms24076619
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer
- (2022) Teresa C. Funk-Hilsdorf et al. Frontiers in Physiology
- Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling
- (2022) Hidenori Moriyama et al. Nature Communications
- Qualitative and Quantitative Effects of Fatty Acids Involved in Heart Diseases
- (2022) Hidenori Moriyama et al. Metabolites
- Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice
- (2022) Hui Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension
- (2022) Shengxin Tang et al. Scientific Reports
- Regulatory Roles of Phospholipase A2 Enzymes and Bioactive Lipids in Mast Cell Biology
- (2022) Yoshitaka Taketomi et al. Frontiers in Immunology
- Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
- (2021) Haowei Zeng et al. Frontiers in Cardiovascular Medicine
- The physiologic basis of pulmonary arterial hypertension
- (2021) Robert Naeije et al. EUROPEAN RESPIRATORY JOURNAL
- Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019
- (2021) Tara E. Scott et al. HYPERTENSION
- Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling
- (2021) Guizhu Liu et al. HYPERTENSION
- Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity
- (2021) Rachid Tobal et al. Frontiers in Medicine
- Perivascular Inflammation in Pulmonary Arterial Hypertension
- (2020) Yijie Hu et al. Cells
- Updating Phospholipase A2 Biology
- (2020) Makoto Murakami et al. Biomolecules
- Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 ( Bmpr2 ) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation
- (2019) Wen Tian et al. CIRCULATION
- Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
- (2019) Andreane Cartier et al. SCIENCE
- Emerging therapeutics in pulmonary hypertension
- (2018) Matthew K. Hensley et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
- (2018) Leigh M. Marsh et al. EUROPEAN RESPIRATORY JOURNAL
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice
- (2018) Guilin Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases
- (2018) Wolf-Hagen Schunck et al. PHARMACOLOGY & THERAPEUTICS
- Pulmonary arterial hypertension: pathogenesis and clinical management
- (2018) Thenappan Thenappan et al. BMJ-British Medical Journal
- Pulmonary arterial hypertension: pathogenesis and clinical management
- (2018) Thenappan Thenappan et al. BMJ-British Medical Journal
- 15-HETE protects pulmonary artery smooth muscle cells against apoptosis via SIRT1 regulation during hypoxia
- (2018) Fujun Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Pro-resolving lipid mediators in vascular disease
- (2018) Michael S. Conte et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia–induced pulmonary arterial hypertension in rats
- (2017) Laxminarayan Bhat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mast cell hyperactivity underpins the development of oxygen-induced retinopathy
- (2017) Kenshiro Matsuda et al. JOURNAL OF CLINICAL INVESTIGATION
- Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation
- (2017) Yuta Shimanaka et al. NATURE MEDICINE
- New Developments in Mast Cell Biology
- (2016) Greer Arthur et al. CHEST
- The impact of mast cells on cardiovascular diseases
- (2016) Eva Kritikou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice
- (2015) Sharath Kandhi et al. AMERICAN JOURNAL OF HYPERTENSION
- Resolvin E1 normalizes contractility, Ca2+sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated Human Pulmonary Arteries.
- (2015) Roddy Hiram et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis
- (2015) Djuro Kosanovic et al. EUROPEAN RESPIRATORY JOURNAL
- Leukotriene B4Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension
- (2015) Jin Qian et al. HYPERTENSION
- Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
- (2015) Adaani E. Frost et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Mast cells in human and experimental cardiometabolic diseases
- (2015) Guo-Ping Shi et al. Nature Reviews Cardiology
- Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
- (2015) Aysar Al-Husseini et al. PLoS One
- The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors
- (2015) Lucie H. Clapp et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Proinflammatory High-Density Lipoprotein Results from Oxidized Lipid Mediators in the Pathogenesis of Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension
- (2015) David J. Ross et al. Pulmonary Circulation
- Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery
- (2014) Roddy Hiram et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Sphingosine Kinase 1/Sphingosine-1-Phosphate Pathway in Pulmonary Arterial Hypertension
- (2014) Jiwang Chen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling
- (2014) Jin Endo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved
- (2014) Tae Chul Moon et al. Frontiers in Immunology
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- 15-LO/15-HETE Mediated Vascular Adventitia Fibrosis via p38 MAPK-Dependent TGF-β
- (2013) Li Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
- (2013) W. Tian et al. Science Translational Medicine
- Substance P Signaling Controls Mast Cell Activation, Degranulation, and Nociceptive Sensitization in a Rat Fracture Model of Complex Regional Pain Syndrome
- (2012) Wen-Wu Li et al. ANESTHESIOLOGY
- Inflammation in Pulmonary Arterial Hypertension
- (2012) Laura C. Price et al. CHEST
- PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension
- (2012) Grazyna Kwapiszewska et al. CIRCULATION RESEARCH
- Molecular pathogenesis of pulmonary arterial hypertension
- (2012) Marlene Rabinovitch JOURNAL OF CLINICAL INVESTIGATION
- Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells
- (2012) Jun Ma et al. JOURNAL OF LIPID RESEARCH
- Mast cells: an expanding pathophysiological role from allergy to other disorders
- (2012) Preet Anand et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Mast Cell Number, Phenotype, and Function in Human Pulmonary Arterial Hypertension
- (2012) Samar Farha et al. Pulmonary Circulation
- C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension
- (2011) David Montani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lysophosphatidic Acid Signaling Protects Pulmonary Vasculature From Hypoxia-Induced Remodeling
- (2011) Hsin-Yuan Cheng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension
- (2011) Beatrijs Bartelds et al. CHEST
- Key Role of 15-Lipoxygenase/15-Hydroxyeicosatetraenoic Acid in Pulmonary Vascular Remodeling and Vascular Angiogenesis Associated With Hypoxic Pulmonary Hypertension
- (2011) Cui Ma et al. HYPERTENSION
- Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension
- (2010) Emilia Falcetti et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mast cells and inflammation
- (2010) Theoharis C. Theoharides et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mast cells promote lung vascular remodelling in pulmonary hypertension
- (2010) J. Hoffmann et al. EUROPEAN RESPIRATORY JOURNAL
- Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids
- (2010) Cosima Arnold et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytochrome P450-Derived Epoxyeicosatrienoic Acids and Pulmonary Hypertension: Central Role of Transient Receptor Potential C6 Channels
- (2010) Annemarieke E Loot et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition
- (2009) Benjamin Keserü et al. CARDIOVASCULAR RESEARCH
- ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat
- (2009) Jun Ma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prostaglandin E 2 Exerts Homeostatic Regulation of Pulmonary Vascular Remodeling in Allergic Airway Inflammation
- (2009) Anders Lundequist et al. JOURNAL OF IMMUNOLOGY
- Roles of lysophosphatidic acid in cardiovascular physiology and disease
- (2008) S SMYTH BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
- (2008) Martina Klein et al. CIRCULATION
- Niacin-induced "Flush" Involves Release of Prostaglandin D2 from Mast Cells and Serotonin from Platelets: Evidence from Human Cells in Vitro and an Animal Model
- (2008) D. Papaliodis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
- (2008) Liliana Moreno-Vinasco et al. PHYSIOLOGICAL GENOMICS
- Prevention of Mast Cell Degranulation by Disodium Cromoglycate Attenuates the Development of Hypoxic Pulmonary Hypertension in Rats Exposed to Chronic Hypoxia
- (2008) Alena Baňasová et al. RESPIRATION
- Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasis
- (2007) Stephen J. Galli et al. JOURNAL OF DERMATOLOGICAL SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started